These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9822073)

  • 1. New antithrombotic agents.
    Weitz JI; Hirsh J
    Chest; 1998 Nov; 114(5 Suppl):715S-727S. PubMed ID: 9822073
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycoprotein IIb/IIIa inhibition in percutaneous coronary interventions.
    Sharma S; Nyitray W; Bhambi B
    JAMA; 2003 Sep; 290(11):1451; author reply 1451. PubMed ID: 13129974
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombocyte IIb/IIIa receptor inhibitors--a new direction in antithrombotic therapy].
    Panchenko EP
    Ter Arkh; 1997; 69(9):66-71. PubMed ID: 9411833
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamic and clinical trials of glycoprotein IIb/IIIa inhibitors and potential relationship of results to dosing.
    Hobbach HP; Schuster P
    Z Kardiol; 2003 Mar; 92(3):213-8. PubMed ID: 12658467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
    Popma JJ; Ohman EM; Weitz J; Lincoff AM; Harrington RA; Berger P
    Chest; 2001 Jan; 119(1 Suppl):321S-336S. PubMed ID: 11157657
    [No Abstract]   [Full Text] [Related]  

  • 6. TP 9201.
    Drugs R D; 1999 May; 1(5):390-1. PubMed ID: 10566073
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic treatment in acute coronary syndromes.
    Hoole SP; Saw J
    Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombotic treatment in acute coronary syndrome].
    Darius H; Rupprecht HJ; Genth-Zotz S; Wittlinger T; Zotz R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S17-22. PubMed ID: 24446037
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic drugs.
    Treat Guidel Med Lett; 2011 Oct; 9(110):61-6; quiz 2 p following 66. PubMed ID: 21941228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
    Shimazaki T; Goto S; Sakakibara M; Eto K; Kim JY; Ichikawa N; Yoshida M; Nagaoka Y; Isshiki T; Handa S
    J Cardiol; 2000 Aug; 36(2):113-21. PubMed ID: 10955255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antithrombotic and antiplatelet treatment.
    Neuhaus KL
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I8-I11. PubMed ID: 10469671
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombotic Therapy in Percutaneous Coronary Intervention.
    Yang X; Ghobrial J; Pinto DS
    Interv Cardiol Clin; 2016 Apr; 5(2):239-247. PubMed ID: 28582207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions.
    Connolly DL; Lip GY; Chin BS
    BMJ; 2002 Dec; 325(7377):1404-7. PubMed ID: 12480860
    [No Abstract]   [Full Text] [Related]  

  • 15. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.
    Kwa AT; Rogers JH
    J Interv Cardiol; 2008 Apr; 21(2):107-17. PubMed ID: 18248357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What have We learned from ESPRIT? What will we learn from TARGET?
    Ferguson JJ
    J Invasive Cardiol; 2000 Jun; 12(6):317-9. PubMed ID: 10859719
    [No Abstract]   [Full Text] [Related]  

  • 17. The original sin committed in years two thousand.
    Cortese B
    J Interv Cardiol; 2011 Oct; 24(5):424-5. PubMed ID: 21929731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction of haemorrhagic risk in acute coronary syndromes].
    Merino A; Roldán I; Marín F; Worner F;
    Med Clin (Barc); 2011 Nov; 137(14):650-5. PubMed ID: 20701931
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs and herbal remedies that affect blood clotting.
    Wynn RL; Bergman SA
    Gen Dent; 2002; 50(6):484-8, 490. PubMed ID: 12572177
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.